- Home
- KTTA vs TTNP Comparison
KTTA vs TTNP Comparison
Compare KTTA & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- TTNP
- Stock Information
- Founded
- KTTA 2020
- TTNP 1991
- Country
- KTTA United States
- TTNP United States
- Employees
- KTTA N/A
- TTNP N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KTTA Health Care
- TTNP Health Care
- Exchange
- KTTA Nasdaq
- TTNP Nasdaq
- Market Cap
- KTTA 2.6M
- TTNP 3.0M
- IPO Year
- KTTA 2021
- TTNP 1996
- Fundamental
- Price
- KTTA $1.30
- TTNP $3.67
- Analyst Decision
- KTTA
- TTNP
- Analyst Count
- KTTA 0
- TTNP 0
- Target Price
- KTTA N/A
- TTNP N/A
- AVG Volume (30 Days)
- KTTA 3.3M
- TTNP 25.0K
- Earning Date
- KTTA 03-28-2025
- TTNP 03-31-2025
- Dividend Yield
- KTTA N/A
- TTNP N/A
- EPS Growth
- KTTA N/A
- TTNP N/A
- EPS
- KTTA N/A
- TTNP N/A
- Revenue
- KTTA N/A
- TTNP N/A
- Revenue This Year
- KTTA N/A
- TTNP N/A
- Revenue Next Year
- KTTA N/A
- TTNP N/A
- P/E Ratio
- KTTA N/A
- TTNP N/A
- Revenue Growth
- KTTA N/A
- TTNP N/A
- 52 Week Low
- KTTA $1.25
- TTNP $3.03
- 52 Week High
- KTTA $9.25
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- KTTA 30.34
- TTNP 50.98
- Support Level
- KTTA $1.32
- TTNP $3.35
- Resistance Level
- KTTA $1.38
- TTNP $4.24
- Average True Range (ATR)
- KTTA 0.26
- TTNP 0.29
- MACD
- KTTA -0.05
- TTNP 0.02
- Stochastic Oscillator
- KTTA 1.92
- TTNP 46.73
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.